MeSH term
Frequency | Condition_Probility | Amino Acid Sequence | 11 | 0.0 |
Animals | 9 | 0.0 |
Cell Line | 2 | 0.0 |
Humans | 36 | 0.0 |
Mice | 6 | 0.0 |
Molecular Sequence Data | 20 | 0.0 |
Mutation | 9 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Homology, Amino Acid | 6 | 0.0 |
Alternative Splicing | 3 | 0.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
Nuclear Proteins/*genetics | 4 | 0.0 |
Organ Specificity | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 27 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Blotting, Southern | 8 | 0.0 |
Chromosome Mapping | 6 | 0.0 |
Gene Expression | 5 | 0.0 |
Male | 22 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Phenotype | 7 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 8 | 0.0 |
Adult | 9 | 0.0 |
Base Sequence | 11 | 0.0 |
Child | 9 | 0.0 |
Child, Preschool | 5 | 0.0 |
Female | 17 | 0.0 |
Karyotyping | 2 | 0.0 |
Nerve Tissue Proteins/*genetics | 5 | 0.0 |
*RNA-Binding Proteins | 10 | 3.0 |
Trans-Activators/*genetics | 2 | 0.0 |
Alleles | 3 | 0.0 |
CpG Islands/genetics | 3 | 2.0 |
Fragile X Syndrome/diagnosis/*genetics | 2 | 15.0 |
Genetic Screening/*methods | 2 | 1.0 |
Trinucleotide Repeat Expansion/genetics | 2 | 5.0 |
Fragile X Syndrome/*genetics | 10 | 6.0 |
Comparative Study | 4 | 0.0 |
CpG Islands/*genetics | 2 | 2.0 |
DNA-Binding Proteins/*genetics | 2 | 0.0 |
*Linkage (Genetics) | 2 | 0.0 |
Mental Retardation/*genetics | 7 | 3.0 |
Middle Aged | 3 | 0.0 |
*Mutation | 3 | 0.0 |
Nerve Tissue Proteins/genetics | 3 | 1.0 |
Pedigree | 5 | 0.0 |
Sex Factors | 2 | 0.0 |
X Chromosome/*genetics | 4 | 1.0 |
Chromosome Fragile Sites | 3 | 2.0 |
Chromosome Fragility | 3 | 5.0 |
*Nuclear Proteins | 17 | 0.0 |
Proteins/*genetics | 11 | 0.0 |
*Trans-Activators | 17 | 2.0 |
*X Chromosome | 3 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
*Transcription Factors | 2 | 0.0 |
Cloning, Molecular | 5 | 0.0 |
Exons | 3 | 0.0 |
Fragile X Syndrome/genetics | 3 | 9.0 |
Models, Genetic | 2 | 0.0 |
Phylogeny | 3 | 0.0 |
Adolescent | 5 | 0.0 |
Heterozygote | 2 | 0.0 |
Polymerase Chain Reaction | 11 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
DNA Methylation | 3 | 0.0 |
Infant | 4 | 0.0 |
Proteins/genetics | 2 | 0.0 |
English Abstract | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Mental Retardation/genetics | 2 | 1.0 |
DNA Primers | 4 | 0.0 |
Intelligence Tests | 2 | 3.0 |
Brain/metabolism | 3 | 0.0 |
Dinucleoside Phosphates | 2 | 11.0 |
*Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
Nuclear Proteins/*genetics/physiology | 2 | 8.0 |
Trans-Activators/*genetics/physiology | 2 | 10.0 |
Syndrome | 2 | 0.0 |
Chromosomes, Human, X/*genetics | 2 | 6.0 |
